In Russia launched the study of drugs for the treatment of coronavirus infection

On behalf of the head of the FMBA Veronika Skvortsova was initiated comparative clinical studies of drugs hydroxychloroquine, mefloquine and Russian drug kalidevi that will be used for the treatment of patients with coronavirus infection. This was reported by the press service of the FMBA.

“6 April 2020 on the basis of SSC center named after them. A. I. Burnazyan of FMBA of Russia has begun clinical studies of drugs and mefloquine hydroxychloroquine in comparison with the drug kalidevi in three groups of patients with different severity”, – said the head of the FMBA of Russia Veronika Skvortsova.

Clinical studies will be conducted involving patients with the new coronavirus infection of SARS-CoV-2, which will arrive in SSC center named after them. A. I. Burnazyan of FMBA of Russia. In KEY patients will be included after signing the informed consent.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]